共 18 条
[1]
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. Parving HH,Lehnert H,Brochner-Mortensen J,et al. The New England Journal of Medicine . 2001
[2]
Renoprotective effects of angiotensinⅡreceptor blockade in type1diabetic patients with diabetic nephropathy. Andersen S,Tarnow L,Rossing P,et al. Kidney International . 2000
[3]
Angiotensin in progressive renal disease: theory and practice. Mastusaka T,Hymes J,Ichikawa I. Journal of the American Society of Nephrology . 1996
[4]
Role of angiotensinⅡin diabetic nephropathy. Leehey DJ,Singh AK,Alavi N,et al. Kidney International .
[5]
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. Lewis EJ,Hunsicker LG,Clarke WR,et al. The New England Journal of Medicine . 2001
[6]
Effects oflosar-tan on renaland cardiovascular outcom es in patients with type2diabetes and nephropathy. BrennerBM,Cooper M E,de Zeeuw D,etal. The New England Journal of Medicine . 2001
[7]
Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats. Kedziora-Kornatowska K. Clinica Chimica Acta . 1999
[8]
The role of angiotensin Ⅱ in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Wolf G,Ziyadeh FN. American Journal of Kidney Diseases . 1997
[9]
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[10]
Angiotensin Ⅱactivates programmed myocyte cell death in vitro. Gigola E,Kajstura J,Li B,et al. Experimental Cell Research . 1997